Use of Wideband Acoustic Immittance in Neonates and Infants

Hammam AlMakadma1, Sreedevi Aithal2,3, Venkatesh Aithal2,3

  • 1Department of Otolaryngology and Communicative Disorders, School of Medicine, University of Louisville, Louisville, Kentucky.

Seminars in Hearing
|March 17, 2023
PubMed

Insights

Wideband acoustic immittance (WAI) offers a sensitive method for assessing infant middle ear function, improving newborn hearing screening accuracy. This technique helps reduce false positives and prioritizes infants needing further diagnostic evaluation for hearing loss.

Area of Science:

  • Audiology
  • Pediatric Healthcare
  • Biomedical Engineering

Background:

  • Universal newborn hearing screening (UNHS) is crucial for early hearing loss identification.
  • High false-positive rates in UNHS are often due to temporary outer/middle ear obstructions.
  • Current methods like single-frequency tympanometry are inefficient for infant middle ear assessment.

Purpose of the Study:

  • To evaluate wideband acoustic immittance (WAI) as an adjunct screening tool for newborn hearing assessments.
  • To demonstrate the utility of WAI, specifically wideband power absorbance (WBA), in assessing infant middle ear status.
  • To provide normative data and clinical guidance for WAI implementation in pediatric audiology.

Main Methods:

  • Review of research on wideband acoustic immittance (WAI) testing in newborns and infants.
  • Presentation of normative data for wideband power absorbance (WBA) in young populations.
  • Description of WAI assessment and interpretation methods, including test-retest reliability.
  • Inclusion of clinical case studies illustrating WAI application.

Main Results:

  • Wideband power absorbance (WBA) shows higher sensitivity than traditional tympanometry for assessing newborn outer/middle ear function.
  • Age-graded norms support the use of WBA in young infants.
  • WAI testing aids in interpreting screening outcomes and prioritizing diagnostic referrals.

Conclusions:

  • Wideband acoustic immittance (WAI) is a promising tool for enhancing the accuracy of newborn hearing screening.
  • Despite its benefits, the clinical adoption of WAI technology remains low.
  • Further implementation and education are needed to leverage WAI for improved infant hearing healthcare.

Related Concept Videos